Georgetown University

Rapidly Growing D.C. Venture Capital Firm Promotes New Partner

Retrieved on: 
Thursday, February 1, 2024

WASHINGTON, Feb. 1, 2024 /PRNewswire/ -- Strategic Cyber Ventures (SCV), a D.C. based venture capital firm that focuses on cybersecurity technology investing, announced that it is promoting one of its top investors to partner.

Key Points: 
  • WASHINGTON, Feb. 1, 2024 /PRNewswire/ -- Strategic Cyber Ventures (SCV), a D.C. based venture capital firm that focuses on cybersecurity technology investing, announced that it is promoting one of its top investors to partner.
  • Chris Ahern, a graduate of the University of Virginia and the Georgetown University MBA program, sees his promotion come as the firm accelerated its investing in the past year.
  • Joining the firm in 2017 not long after it was founded, Chris quickly became the lead investor behind several of SCV's strongest investments.
  • Thomas went on to say "Chris has grown a passion for cybersecurity that makes him a perfect fit for our firm."

Balance Point Announces Investment Team Promotions and Two New Hires Across Investment and Investor Relations Teams

Retrieved on: 
Wednesday, January 31, 2024

The firm is also pleased to announce the addition of two new associates on the investment and investor relations teams, Wills Danielsen and Nina Lorusso, respectively.

Key Points: 
  • The firm is also pleased to announce the addition of two new associates on the investment and investor relations teams, Wills Danielsen and Nina Lorusso, respectively.
  • Seth Alvord, Managing Partner said, "We are very pleased to promote Grant, Dan, and James, each of whom have added significant value to Balance Point.
  • Their expertise and dedication to our firm and portfolio companies has greatly contributed to the success of our investment platform.
  • Grant joined Balance Point in 2017 as a Senior Associate and most recently was a Senior Vice President.

Immunovia appoints Norma Alonzo Palma as new Vice President of Clinical and Medical Affairs

Retrieved on: 
Wednesday, January 31, 2024

LUND, Sweden, Jan. 31, 2024 /PRNewswire/ -- Immunovia (IMMNOV: Nasdaq Stockholm), the diagnostics company with the mission to increase pancreatic cancer survival rates through early detection, today announces the appointment of Norma Alonzo Palma, PhD as Vice President of Clinical and Medical Affairs.

Key Points: 
  • LUND, Sweden, Jan. 31, 2024 /PRNewswire/ -- Immunovia (IMMNOV: Nasdaq Stockholm), the diagnostics company with the mission to increase pancreatic cancer survival rates through early detection, today announces the appointment of Norma Alonzo Palma, PhD as Vice President of Clinical and Medical Affairs.
  • As announced in July 2023, Immunovia significantly restructured to focus its resources on the company's next-generation blood test for early detection of pancreatic cancer.
  • Norma most recently held the position of VP of Medical Affairs at Aadi Biosciences where she developed and executed the medical strategy and plan.
  • She will also strengthen Immunovia's partnerships with key opinion leaders, leading clinicians, and payers," says Jeff Borcherding, CEO and President of Immunovia.

Immunovia appoints Norma Alonzo Palma as new Vice President of Clinical and Medical Affairs

Retrieved on: 
Wednesday, January 31, 2024

LUND, Sweden, Jan. 31, 2024 /PRNewswire/ -- Immunovia (IMMNOV: Nasdaq Stockholm), the diagnostics company with the mission to increase pancreatic cancer survival rates through early detection, today announces the appointment of Norma Alonzo Palma, PhD as Vice President of Clinical and Medical Affairs.

Key Points: 
  • LUND, Sweden, Jan. 31, 2024 /PRNewswire/ -- Immunovia (IMMNOV: Nasdaq Stockholm), the diagnostics company with the mission to increase pancreatic cancer survival rates through early detection, today announces the appointment of Norma Alonzo Palma, PhD as Vice President of Clinical and Medical Affairs.
  • As announced in July 2023, Immunovia significantly restructured to focus its resources on the company's next-generation blood test for early detection of pancreatic cancer.
  • Norma most recently held the position of VP of Medical Affairs at Aadi Biosciences where she developed and executed the medical strategy and plan.
  • She will also strengthen Immunovia's partnerships with key opinion leaders, leading clinicians, and payers," says Jeff Borcherding, CEO and President of Immunovia.

Implications of Generative AI on U.S. National Security National Conference

Retrieved on: 
Monday, January 29, 2024

Washington, D. C., Jan. 29, 2024 (GLOBE NEWSWIRE) -- The explosive growth of generative artificial intelligence (AI) has significant implications for U.S. national security, yet the conversation around this topic has been fragmented.

Key Points: 
  • Washington, D. C., Jan. 29, 2024 (GLOBE NEWSWIRE) -- The explosive growth of generative artificial intelligence (AI) has significant implications for U.S. national security, yet the conversation around this topic has been fragmented.
  • Now national military, policy, and technology professionals will delve deeply into how AI is reshaping the national security landscape during a Jan. 31 public conversation, “ Generative AI and National Security .” A keynote and panel conversations will cover the short- and medium-term implications of generative AI for America’s national security.
  • “AI's rapid evolution, and particularly the rise of generative AI like Open AI’s ChatGPT, is transforming the national security field.
  • Fostering responsible, inclusive discussions on generative AI, especially regarding ethics and security, is critical to navigating obstacles and providing solutions in this ever-changing landscape."

Managing Work and Learning Spaces in 2024 – Six Trends to Watch

Retrieved on: 
Friday, January 26, 2024

2024 will be more about not only accepting but embracing the hybrid work reality and learning to thrive in it.

Key Points: 
  • 2024 will be more about not only accepting but embracing the hybrid work reality and learning to thrive in it.
  • This will lead to the emergence of specialized roles such as hospitality consultants and experience managers, who will be instrumental in crafting and managing these dynamic spaces.
  • Offices will evolve into multifunctional hubs, active seven days a week, seamlessly transitioning between traditional office work, university classrooms, and community event spaces.
  • “Understanding space use for neurodiverse employees will also gain a lot of attention in 2024 and help companies attract and retain unique talent.

Bright Green Corporation announces the agreement to acquire platform technologies and associated intellectual property from C2 Wellness Corp.

Retrieved on: 
Thursday, January 25, 2024

Grants, New Mexico, Jan. 25, 2024 (GLOBE NEWSWIRE) -- Bright Green Corporation (NASDAQ: BGXX) today announced the agreement to purchase assets from C2 Wellness Corporation.

Key Points: 
  • Grants, New Mexico, Jan. 25, 2024 (GLOBE NEWSWIRE) -- Bright Green Corporation (NASDAQ: BGXX) today announced the agreement to purchase assets from C2 Wellness Corporation.
  • (“C2”), a Wyoming registered company with an address at 30 N Gould St, Ste R, Sheridan, WY, that owns certain platform technologies and associated intellectual property invented and developed by the scientific team of C2.
  • The purchase is for 5 million shares of common stock of Bright Green Corporation payable to all shareholders of C2.
  • This groundbreaking collaboration involves the acquisition of innovative CBD and THC-based molecules from C2 Wellness Corp by Bright Green Corporation,” said Lynn Stockwell.

Cloudforce Announces Winners in 10th Annual Hoya Hacks Hackathon

Retrieved on: 
Monday, January 29, 2024

Every year, Hoya Hacks welcomes students with diverse skills and backgrounds to collaborate, innovate, and build solutions for positive social change over three dynamic days.

Key Points: 
  • Every year, Hoya Hacks welcomes students with diverse skills and backgrounds to collaborate, innovate, and build solutions for positive social change over three dynamic days.
  • "At Cloudforce, we are committed to nurturing the next generation of engineering talent, alongside our partners at Microsoft."
  • "Our sponsorship of Hoya Hacks aligns perfectly with our mission to contribute to our community through educating and exposing bright young minds to the tools of tomorrow.
  • "Cloudforce aided Hoya Hacks to push the envelope this year in terms of complexity of project submissions.

HPE Appoints Kristin Major Chief People Officer

Retrieved on: 
Tuesday, January 23, 2024

Hewlett Packard Enterprise (NYSE: HPE) today named Kristin Major as executive vice president and chief people officer (CPO), effective February 1, 2024, reporting to president and chief executive officer Antonio Neri.

Key Points: 
  • Hewlett Packard Enterprise (NYSE: HPE) today named Kristin Major as executive vice president and chief people officer (CPO), effective February 1, 2024, reporting to president and chief executive officer Antonio Neri.
  • View the full release here: https://www.businesswire.com/news/home/20240123406490/en/
    Major has been with HPE since 2011, most recently serving as senior vice president of human resources (HR) and chief talent officer.
  • Over the course of her career with HPE, Major has led HR for HPE GreenLake, HPE Aruba Networking, the HPE Transformation Office, and HPE’s chief technology officer.
  • Together we have made HPE a fantastic place to work that cultivates extraordinary leaders like Kristin,” said Neri.

STEMCELL Technologies Announces Acquisition of Propagenix Inc.

Retrieved on: 
Friday, January 19, 2024

STEMCELL Technologies, Canada’s largest biotechnology company, is pleased to announce the acquisition of Propagenix Inc.—a Maryland-based biotechnology company focused on developing technologies to enable new approaches in regenerative medicine.

Key Points: 
  • STEMCELL Technologies, Canada’s largest biotechnology company, is pleased to announce the acquisition of Propagenix Inc.—a Maryland-based biotechnology company focused on developing technologies to enable new approaches in regenerative medicine.
  • View the full release here: https://www.businesswire.com/news/home/20240119648511/en/
    STEMCELL Technologies, Canada’s largest biotechnology company, is pleased to announce the acquisition of Propagenix Inc.—a Maryland-based biotechnology company focused on developing technologies to enable new approaches in regenerative medicine.
  • (Pictured: STEMCELL's headquarters in Vancouver, BC) (Photo: Business Wire)
    “The acquisition of Propagenix is an important step in STEMCELL’s growth journey and an achievement for Canada's biotechnology industry,” said Dr. Allen Eaves, President and CEO, STEMCELL.
  • “We are delighted that the amazing team of scientists at STEMCELL will ensure Propagenix technologies and capabilities for epithelial cell biology are deployed to their fullest to serve the life science research community,” said Dr. Brian Pollok on behalf of Propagenix co-founders.